Eton Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Eton Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $509K.
  • Eton Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.22M, a 380% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$1.19M, a 85.6% increase from 2022.
  • Eton Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$8.26M, a 453% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$1.5M, a 94.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.19M +$7.07M +85.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$8.26M -$6.77M -453% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$1.5M +$25.6M +94.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$27.1M -$8.51M -45.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$18.6M -$8.28M -80.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 -$10.3M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.